Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients

BMC Cancer

Table 3 Distribution of cardiac risk factors among patients with abnormal echo compared to those with normal echo - Fisher’s Exact test

Variable	Normal echo	Abnormal echo	P value
Diabetes			0.3
No	171 (79.9)	4 (66.7)
Yes	34 (15.9)	2 (33.3)
Not available	9 (4.2)	2 (33.3)
Dyslipidemia			0.3
No	166 (77.7)	4 (66.7)
Yes	38 (17.6)	2 (33.3)
Not available	10 (4.7)	2 (33.3)
Hypertension			0.2
No	152 (71)	3 (50)
Yes	52 (24.3)	3 (50)
Not available	10 (4.7)	3 (50)
^aCAD			0.01
No	199 (93)	4 (66.7)
Yes	5 (2.3)	2 (33.3)
Not available	10 (4.7)	2 (33.3)
Smoking status			0.1
No	126 (58.9)	5 (83.3)
Yes	74 (34.6)	0 (0)
Not available	14 (6.5)	1(16.7)
^bBMI			1
<25	55 (25.7)	2 (33.3)
25-30	74 (34.6)	2 (33.3)
>30	68 (31.8)	1 (16.7)
Not available	17 (7.9)	1 (16.7)